Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Plos One
|
May 14, 2013
Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models
Anna Tesei, Carlo Leonetti, Marzia Di Donato, et al.
Radiation Oncology (London, England)
|
November 5, 2013
In vitro irradiation system for radiobiological experiments
Anna Tesei, Anna Sarnelli, Chiara Arienti, et al.
Cell Death & Disease
|
January 25, 2022
Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma
Michele Zanoni, Alba Clara Sarti, Alice Zamagni, et al.
Future Microbiology
|
October 5, 2017
Liquid biopsy in the diagnosis of HPV DNA in breast lesions
Sabrina De Carolis, Alice Pellegrini, Donatella Santini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 27, 2014
Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells
Lara Gibellini, Marcello Pinti, Federica Boraldi, et al.
European Journal of Medicinal Chemistry
|
November 7, 2016
Synthesis and biological evaluation of new aryl-alkyl(alkenyl)-4-benzylpiperidines, novel Sigma Receptor (SR) modulators, as potential anticancer-agents
Marta Rui, Daniela Rossi, Annamaria Marra, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 31, 2026
Sustainable Chemistry and Preclinical Characterization of RC-106·HCl: A Brain-Penetrant Pan Sigma Receptor Modulator for Glioblastoma
Noemi Marino, Roberta Listro, Chiara Milanese, et al.
Frontiers in Pharmacology
|
June 4, 2019
Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic Cancer
Anna Tesei, Michela Cortesi, Sara Pignatta, et al.
Journal of Medicinal Chemistry
|
August 15, 2014
A new avenue toward androgen receptor pan-antagonists: C2 sterically hindered substitution of hydroxy-propanamides
Andrea Guerrini, Anna Tesei, Claudia Ferroni, et al.
Frontiers in Oncology
|
April 16, 2021
Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
Donatella Arpa, Elisabetta Parisi, Giulia Ghigi, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Plos One
|
May 14, 2013
Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models
Anna Tesei, Carlo Leonetti, Marzia Di Donato, et al.
Radiation Oncology (London, England)
|
November 5, 2013
In vitro irradiation system for radiobiological experiments
Anna Tesei, Anna Sarnelli, Chiara Arienti, et al.
Cell Death & Disease
|
January 25, 2022
Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma
Michele Zanoni, Alba Clara Sarti, Alice Zamagni, et al.
Future Microbiology
|
October 5, 2017
Liquid biopsy in the diagnosis of HPV DNA in breast lesions
Sabrina De Carolis, Alice Pellegrini, Donatella Santini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 27, 2014
Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells
Lara Gibellini, Marcello Pinti, Federica Boraldi, et al.
European Journal of Medicinal Chemistry
|
November 7, 2016
Synthesis and biological evaluation of new aryl-alkyl(alkenyl)-4-benzylpiperidines, novel Sigma Receptor (SR) modulators, as potential anticancer-agents
Marta Rui, Daniela Rossi, Annamaria Marra, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 31, 2026
Sustainable Chemistry and Preclinical Characterization of RC-106·HCl: A Brain-Penetrant Pan Sigma Receptor Modulator for Glioblastoma
Noemi Marino, Roberta Listro, Chiara Milanese, et al.
Frontiers in Pharmacology
|
June 4, 2019
Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic Cancer
Anna Tesei, Michela Cortesi, Sara Pignatta, et al.
Journal of Medicinal Chemistry
|
August 15, 2014
A new avenue toward androgen receptor pan-antagonists: C2 sterically hindered substitution of hydroxy-propanamides
Andrea Guerrini, Anna Tesei, Claudia Ferroni, et al.
Frontiers in Oncology
|
April 16, 2021
Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
Donatella Arpa, Elisabetta Parisi, Giulia Ghigi, et al.
Page
of 10